|Bid||12.42 x 1100|
|Ask||12.44 x 1800|
|Day's range||12.10 - 12.66|
|52-week range||5.04 - 23.88|
|Beta (5Y monthly)||0.91|
|PE ratio (TTM)||N/A|
|Earnings date||16 Apr 2020|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||14 Oct 1999|
|1y target est||6.67|
Today, Rite Aid (NYSE: RAD) announced a new partnership with Instacart, which will allow customers to conveniently order and receive essential healthcare and grocery items delivered directly to their homes during the COVID-19 pandemic and beyond.
Rite Aid (NYSE: RAD) will significantly expand its COVID-19 testing effort with the addition of 46 no-charge testing sites, most of which will operate through its stores’ drive-through windows, beginning May 11, 2020. Rite Aid is also expanding COVID-19 testing criteria at all testing sites to include adults who are not exhibiting any symptoms of the virus, effective immediately in accordance with the Centers for Disease Control and Prevention guidance.
If you've been tracking Rite Aid (NYSE: RAD) in recent weeks, you may have noticed an alarming trend. While its competitor Walgreens Boots Alliance (NASDAQ: WBA) remained a relatively attractive value stock in April as stocks rebounded out of the worst market plunge since the Great Recession, Rite Aid has been all over the map. The company's revenue plunged significantly in the 2018 fiscal year, and things just haven't been the same since.
Rite Aid (NYSE: RAD) has expanded COVID-19 testing criteria to include all individuals 18 and older exhibiting any of the following symptoms: fever, cough, shortness of breath, chills, repeated shaking with chills, muscle pain, headache, sore throat, new loss of taste or smell.
Rite Aid (RAD) is aggressively expanding COVID-19 testing locations, marked by the opening of its 25th site at Richmond, VA, to help curb the effects of the pandemic.
Rite Aid continues to expand COVID-19 testing sites with its 25th location opening on Thursday, April 23, in Richmond, Va.
U.S. stocks surged on Friday, thanks to investor optimism over a possible cure to the deadly coronavirus and President Donald Trump's plans to gradually reopen U.S. economy.
Rite Aid continues to expand COVID-19 testing sites with eleven new locations opening Wednesday, April 22.
Rite Aid (NYSE: RAD) continues to expand COVID-19 testing sites with new locations opening Monday, April 20, in New York, New Jersey, Michigan and Ohio, through its partnership with the U.S. Department of Health and Human Services (HHS).
Strong revenues at pharmacy services and retail pharmacy segments aided Rite Aid's (RAD) Q4 results. Further, management issued FY21 view, which reflects no COVID-19 impacts.
Rite Aid (NYSE: RAD) continues to expand COVID-19 testing sites with new locations opening Saturday, in Waldwick, NJ and Valley Cottage, NY, through its partnership with the U.S. Department of Health and Human Services (HHS).
Initial and Continuing Jobless Claims, Housing Starts and Building Permits, and the Philly Fed join the latest batch of Q1 earnings reports this morning.
Rite Aid (RAD) delivered earnings and revenue surprises of -184.62% and 1.21%, respectively, for the quarter ended February 2020. Do the numbers hold clues to what lies ahead for the stock?
CAMP HILL, Pa. (AP) _ Rite Aid Corp. (RAD) on Thursday reported a loss of $324.7 million in its fiscal fourth quarter. The Camp Hill, Pennsylvania-based company said it had a loss of $6.08 per share. Rite Aid expects full-year results to range from a loss of 22 cents per share to earnings of 19 cents per share, with revenue in the range of $22.5 billion to $22.9 billion.
Rite Aid Corporation (NYSE: RAD) today reported operating results for its fourth quarter and fiscal year ended February 29, 2020.
Rite Aid (RAD) adds another testing location at a Rite Aid store in Pennsylvania to help curb the effects of coronavirus pandemic.
Rite Aid (NYSE: RAD) continues to expand COVID-19 testing sites with new locations opening tomorrow, in York, Pa., and Pittsburgh, Pa., through its partnership with the White House Coronavirus Task Force.
Rite Aid (RAD) has been working at the forefront by providing essential goods and medicines as well as assisting with coronavirus testing and virus-related information.